dr. george demetri explains the side effects associated with regorafenib
Published 12 years ago • 910 plays • Length 1:21Download video MP4
Download video MP3
Similar videos
-
1:49
dr. george demetri describes the mechanism of action of regorafenib in gist
-
1:23
dr. george demetri discusses regorafenib for patients with gist trial results
-
11:24
managing toxicities associated with regorafenib
-
9:39
george d. demetri: grid trial
-
3:32
dr. george demetri on blood test for cancer mutations | dana-farber cancer institute
-
2:29
regorafenib as a treatment for gist patients - george demetri
-
26:20
colorectal cancer: the link between the immune microenvironment and outcomes
-
32:23
human prion diseases/creutzfeld-jacob disease - diagnosis and treatment - richard knight
-
5:19
stivarga moa. austin visuals
-
5:31
practical advice for using regorafenib
-
10:02
role of the multikinase inhibitor regorafenib in metastatic colorectal cancer
-
1:47
dr. axel grothey on the time course of regorafenib-associated adverse events
-
2:58
treatment response and side effects with regorafenib
-
1:02
regorafenib as a treatment for gist (gastrointestinal stromal tumour) patients
-
16:17
george demetri, md - oral history | dana-farber cancer institute
-
0:42
dr. bendell on the future of regorafenib for patients with crc
-
9:34
regorafenib in colorectal cancer
-
2:03
dr. axel grothey on the side effect profile of regorafenib in metastatic colorectal cancer
-
3:54
colorectal cancer: patient follow-up with regorafenib
-
8:14
optimizing treatment with regorafenib in metastic colorectal cancer
-
2:38
regorafenib lengthens suvival in colorectal cancer with kras mutation
-
12:53
gist 2010 - dr. george demetri